ATE131283T1 - Konservierung von zellen als kontrolle oder normalmass in zellularer analyse. - Google Patents

Konservierung von zellen als kontrolle oder normalmass in zellularer analyse.

Info

Publication number
ATE131283T1
ATE131283T1 AT91306643T AT91306643T ATE131283T1 AT E131283 T1 ATE131283 T1 AT E131283T1 AT 91306643 T AT91306643 T AT 91306643T AT 91306643 T AT91306643 T AT 91306643T AT E131283 T1 ATE131283 T1 AT E131283T1
Authority
AT
Austria
Prior art keywords
cells
preservation
normal
control
cellular analysis
Prior art date
Application number
AT91306643T
Other languages
English (en)
Inventor
Kenneth A Davis
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE131283T1 publication Critical patent/ATE131283T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56977HLA or MHC typing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00Reference solutions for assays of biological material
    • G01N2496/05Reference solutions for assays of biological material containing blood cells or plasma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91306643T 1990-07-23 1991-07-22 Konservierung von zellen als kontrolle oder normalmass in zellularer analyse. ATE131283T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55693490A 1990-07-23 1990-07-23

Publications (1)

Publication Number Publication Date
ATE131283T1 true ATE131283T1 (de) 1995-12-15

Family

ID=24223416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91306643T ATE131283T1 (de) 1990-07-23 1991-07-22 Konservierung von zellen als kontrolle oder normalmass in zellularer analyse.

Country Status (10)

Country Link
US (1) US6008052A (de)
EP (1) EP0469766B1 (de)
JP (1) JP2573757B2 (de)
AT (1) ATE131283T1 (de)
AU (1) AU645807B2 (de)
CA (1) CA2043045C (de)
DE (1) DE69115154T2 (de)
ES (1) ES2083529T3 (de)
IE (1) IE76319B1 (de)
NZ (1) NZ238236A (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661296B2 (en) * 1991-01-11 1995-07-20 Cobe Laboratories Inc. Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
US5459073A (en) * 1991-05-08 1995-10-17 Streck Laboratories, Inc. Method and composition for preserving antigens and process for utilizing cytological material produced by same
US5460797A (en) * 1991-05-08 1995-10-24 Streck Laboratories, Inc. Method for fixing tissues and cells for analysis using oxazolidine compounds
US5849517A (en) * 1991-05-08 1998-12-15 Streck Laboratories, Inc. Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
JPH05142122A (ja) * 1991-11-15 1993-06-08 Olympus Optical Co Ltd 固相細胞の乾燥固定方法
US5858790A (en) * 1996-06-26 1999-01-12 Abbott Laboratories Hematology reference control and method of preparation
US6071745A (en) 1997-06-27 2000-06-06 Bio-Rad Laboratories Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
US20010018192A1 (en) 1998-02-12 2001-08-30 Terstappen Leon W.M.M. Labeled cells for use as an internal functional control in rare cell detection assays
US7282350B2 (en) 1998-02-12 2007-10-16 Immunivest Corporation Labeled cell sets for use as functional controls in rare cell detection assays
FR2781055B1 (fr) * 1998-07-09 2000-10-13 Immunotech Sa Reactif et methode pour la permeabilisation et l'identification des erythrocytes
US6528309B2 (en) * 2001-03-19 2003-03-04 The Regents Of The University Of California Vacuum-mediated desiccation protection of cells
US7572574B2 (en) 2002-04-26 2009-08-11 Riken Method of measuring neprilysin activity
US6927062B2 (en) * 2002-11-25 2005-08-09 Agdia, Inc. Controls and standards for assays and method for manufacture thereof
US7381440B2 (en) * 2003-06-06 2008-06-03 The United States Of America As Represented By The Secretary Of The Navy Biological laser printing for tissue microdissection via indirect photon-biomaterial interactions
CN100360925C (zh) * 2005-05-12 2008-01-09 杭州市中医院 一一对照式玻片检测方法
US20070015134A1 (en) * 2005-07-15 2007-01-18 Beckman Coulter, Inc. Quantitative stabilized cell reference control products and methods
CN101802182A (zh) 2007-08-21 2010-08-11 诺达利蒂公司 用于诊断、预后和治疗方法的方法
CN108088824B (zh) 2008-03-14 2021-06-04 雅培快速诊断耶拿有限公司 一种用于检测分析物的系统
CA2730191C (en) * 2008-07-11 2018-06-19 Secretary Of State For Health Stimulated cell standards
PT3299800T (pt) 2009-03-16 2020-03-04 Alere Tech Gmbh Dispositivo microfluídico
US20120088230A1 (en) 2010-10-11 2012-04-12 Monique Givens System And Method For Cell Analysis
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
CN101957282B (zh) * 2010-10-20 2013-06-05 杭州市中医院 一种单细胞或组织微粒悬液的制备方法及用途
ES2895391T3 (es) 2011-12-27 2022-02-21 Abbott Lab Análisis celular de fluidos corporales
WO2014070235A1 (en) 2012-10-29 2014-05-08 Mbio Diagnostics, Inc. Biological particle identification system, cartridge and associated methods
WO2022132985A1 (en) 2020-12-16 2022-06-23 Juno Therapeutics, Inc. Threshold gating for flow cytometry methods
JPWO2024143263A1 (de) 2022-12-26 2024-07-04

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4731330A (en) * 1986-07-01 1988-03-15 Biotrack, Inc. Whole blood control sample
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
JPH01107154A (ja) * 1987-10-20 1989-04-25 Seitetsu Kagaku Co Ltd 加工赤血球およびその製造方法
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same

Also Published As

Publication number Publication date
CA2043045C (en) 1999-08-10
AU645807B2 (en) 1994-01-27
DE69115154T2 (de) 1996-07-04
US6008052A (en) 1999-12-28
EP0469766B1 (de) 1995-12-06
CA2043045A1 (en) 1992-01-24
JPH05133957A (ja) 1993-05-28
JP2573757B2 (ja) 1997-01-22
IE76319B1 (en) 1997-10-22
EP0469766A1 (de) 1992-02-05
IE911734A1 (en) 1992-01-29
AU7724891A (en) 1992-02-06
ES2083529T3 (es) 1996-04-16
DE69115154D1 (de) 1996-01-18
NZ238236A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
ATE131283T1 (de) Konservierung von zellen als kontrolle oder normalmass in zellularer analyse.
ATE380793T1 (de) N-phenyl-alkylsulfonamid-derivate, deren herstellung und deren verwendung als alpha1a/1l- adrenoceptor agonisten
DE69334245D1 (de) Acrylisches Copolymer, teilweise oder vollständig wasserlöslich, vernetzt oder unvernetzt und seine Verwendung
ES2077646T3 (es) Prepolimeros utiles en dispositivos biomedicos.
BR9507140A (pt) Proteina dna vetor célula capaz de expressar uma proteina kit e processo de teste preparado de luciferase e uso de uma luciferase
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
CA2047154A1 (en) Hair dye composition and its application method
DE69030040D1 (de) Informationsspeicherung, -zugriff und -verarbeitung
DE59009878D1 (de) Farbstoffmischungen und deren Verwendung.
FI852610L (fi) Dihydropyridiner innehaollande fasta laekemedelsprodukter och foerfarande foer deras framstaellning.
FI894804A0 (fi) Anvaendning av zink- och jaernhydroxid som adjuvanter av antigenloesningar och pao detta saett effektiverade antigenloesningar.
DK0563085T3 (da) Hidtil ukendte præparater
DE59103922D1 (de) Mischester und seine verwendung als gleitmittel in kunststoff-formmassen.
DE68912462D1 (de) Xanthenfarbstoffe.
DE69217783D1 (de) 3-Phenoxybenzyl(iden)pyrrolidin-Derivate, deren Herstellung und deren Verwendung als muskarin-cholinerge Mittel
FI941362A7 (fi) Ternaarinen polymeeriseos ja sen käyttö
DE3676482D1 (de) Lichtempfindliche schutzmittel und deren anwendung.
DE59410457D1 (de) Mittel zur beeinflussung von hyperaktivierten immunologischen effektorzellen
DE68906992D1 (de) Indanylring enthaltende pyrethinester, deren herstellung und deren anwendung als pestizide.
EE03362B1 (et) Raadiotelefon, selle kasutamise meetod ning väline võimendusseade
PT942978E (pt) Metodos para produzir o complexos promotor da anafase
DE69005312D1 (de) Stromart abtast-und-halteverstärker.
DE68909191D1 (de) Symmetrische Oxazin-Verbindungen und ihre Verwendung als faserreaktive Farbstoffe.
ATE88328T1 (de) Verwendung von efomycinen als leistungsfoerderer bei tieren, efomycine und ihre herstellung.
DE69106004D1 (de) Komparator mit selbsttätigem abgleich und niedrigem leistungsverbrauch.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties